Analgesic Efficacy of Capsaicin 8% Patch (QUTENZA®) in Coccygodygnia
ConditionCoccyx Disorder
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNantes University Hospital
About this trial
A retrospective study over a period of 6 years to explore analgesic efficacy of 8% Capsaicin patch (QUTENZA®) in coccygodynic patients, as well as neuropathic predictive factors of therapeutic response.
Eligibility criteria
Qualifiers
Patients who received topical Capsaicin 8% patch therapy for the treatment of their coccygodygnia between August 2016 and August 2022
Disqualifiers
Patients who have already received 8% Capsaicin patch topical treatment in coccyx area.
Trial design
Treatments tested in this trial
- Capsaicin
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov